Home ArsenalBio

ArsenalBio

In operation
Series C
Cell Therapy Developer
Basic
Enterprise Profile

Basic Information

ArsenalBio is a programmable cell therapy company dedicated to creating efficient and accessible immune cell therapies for patients. ArsenalBio is committed to integrating technologies such as CRISPR-based genomic engineering, large-scale and high-throughput target identification, synthetic biology, and machine learning to drive the discovery of new paradigms in immune cell therapy.
ArsenalBio Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2019
--

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy Gene Therapy Biological Drug Production
Technology
Machine Learning Gene Editing Immunological Techniques Cell Technology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy AI+Pharmaceuticals